Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.
Saotome K, Chiyoda T, Aimono E, Nakamura K, Tanishima S, Nohara S, Okada C, Hayashi H, Kuroda Y, Nomura H, Susumu N, Iwata T, Yamagami W, Kataoka F, Nishihara H, Aoki D.
Saotome K, et al. Among authors: hayashi h.
Cancer Med. 2020 Oct;9(20):7407-7417. doi: 10.1002/cam4.3383. Epub 2020 Aug 19.
Cancer Med. 2020.
PMID: 32813918
Free PMC article.